Lasofoxifene (Oporia) is a product of a joint development programme between Pfizer and Ligand Pharmaceuticals, which is a selective estrogen receptor modulator (SERM) under development for the prevention and treatment of osteoporosis and for the treatment of vaginal atrophy. Osteoporosis affects nearly 8 million American women. An additional 22 million women are likely to have low bone mass, placing them at increased risk of osteoporosis. In the US osteoporosis is responsible for more than 1....
| Currently you cannot purchase Lassofoxifene as it might be not available for sale online or on local pharmacy. Subscribe below and we will inform you where and when you can order Lassofoxifene |
| Lassofoxifene Availability Subscription Form |
|
| |
| Note: We will email you when Lassofoxifene is available for sale online or in pharmacy in your country. |
|
|
|
|